Relevance and clinicopathologic relationship of BRAF V600E, TERT and NRAS mutations for papillary thyroid carcinoma patients in Northwest China

被引:0
|
作者
Meiling Huang
Changjiao Yan
Jingjing Xiao
Ting Wang
Rui Ling
机构
[1] The Fourth Military Medical University,Department of Thyroid, Breast, and Vascular Surgery, Xijing Hospital
来源
关键词
BRAF V600E mutation; TERT mutation; NRAS mutation; Co-mutations; Papillary thyroid carcinoma;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Coexistence of TERT Promoter Mutations and the BRAF V600E Alteration and Its Impact on Histopathological Features of Papillary Thyroid Carcinoma in a Selected Series of Polish Patients
    Rusinek, Dagmara
    Pfeifer, Aleksandra
    Krajewska, Jolanta
    Oczko-Wojciechowska, Malgorzata
    Handkiewicz-Junak, Daria
    Pawlaczek, Agnieszka
    Zebracka-Gala, Jadwiga
    Kowalska, Malgorzata
    Cyplinska, Renata
    Zembala-Nozynska, Ewa
    Chekan, Mykola
    Chmielik, Ewa
    Kropinska, Aleksandra
    Lamch, Roman
    Jurecka-Lubieniecka, Beata
    Jarzab, Barbara
    Czarniecka, Agnieszka
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (09)
  • [32] In Japanese patients with papillary thyroid carcinoma, TERT promoter mutation is associated with poor prognosis, in contrast to BRAF V600E mutation
    Nasirden, Almira
    Saito, Tsuyoshi
    Fukumura, Yuki
    Hara, Kieko
    Akaike, Keisuke
    Kurisaki-Arakawa, Aiko
    Asahina, Miki
    Yamashita, Atsushi
    Tomomasa, Ran
    Hayashi, Takuo
    Arakawa, Atsushi
    Yao, Takashi
    VIRCHOWS ARCHIV, 2016, 469 (06) : 687 - 696
  • [33] BRAF V600E mutation is associated with aggressive behaviour in the papillary variant of papillary thyroid carcinoma
    Corominas-Cishek, A.
    Gonzalez, M.
    Perez, A.
    Caamano, V.
    Muniz, G.
    Cerda, N.
    Gaafar, A.
    Lopez, J. I.
    VIRCHOWS ARCHIV, 2013, 463 (02) : 152 - 152
  • [34] TERT and BRAF V600E mutations in thyroid cancer of World Trade Center Responders
    van Gerwen, Maaike
    Cerutti, Janete Maria
    Mendes, Thais Biude
    Brody, Rachel
    Genden, Eric
    Riggins, Gregory J.
    Taioli, Emanuela
    CARCINOGENESIS, 2023, 44 (04) : 350 - 355
  • [35] Clinicopathologic significance of BRAF V600E mutation in papillary carcinomas of the thyroid -: A meta-analysis
    Lee, Ju-Han
    Lee, Eung-Seok
    Kim, Young-Sik
    CANCER, 2007, 110 (01) : 38 - 46
  • [36] BRAF V600E and TERT Promoter Mutations Cooperatively Identify the Most Aggressive Papillary Thyroid Cancer With Highest Recurrence
    Xing, Mingzhao
    Liu, Rengyun
    Liu, Xiaoli
    Murugan, Avaniyapuram Kannan
    Zhu, Guangwu
    Zeiger, Martha A.
    Pai, Sara
    Bishop, Justin
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (25) : 2718 - +
  • [37] Frequent BRAF V600E and Absence of TERT Promoter Mutations Characterize Sporadic Pediatric Papillary Thyroid Carcinomas in Japan
    Oishi, Naoki
    Kondo, Tetsuo
    Nakazawa, Tadao
    Mochizuki, Kunio
    Inoue, Tomohiro
    Kasai, Kazunari
    Tahara, Ippei
    Yabuta, Tomonori
    Hirokawa, Mitsuyoshi
    Miyauchi, Akira
    Katoh, Ryohei
    ENDOCRINE PATHOLOGY, 2017, 28 (02) : 103 - 111
  • [38] BRAF V600E mutation co-existing with oncogenic mutations is associated with aggressive clinicopathologic features and poor prognosis in papillary thyroid carcinoma
    Bandoh, Nobuyuki
    Goto, Takashi
    Kato, Yasutaka
    Kubota, Akinobu
    Sakaue, Shota
    Takeda, Ryuhei
    Hayashi, Shuto
    Hayashi, Misaki
    Baba, Shogo
    Yamaguchi-Isochi, Tomomi
    Nishihara, Hiroshi
    Kamada, Hajime
    ASIAN JOURNAL OF SURGERY, 2024, 47 (01) : 413 - 419
  • [39] BRAF V600E Mutation and Papillary Thyroid Cancer Reply
    Cappola, Anne R.
    Mandel, Susan J.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 310 (05): : 535 - 536
  • [40] BRAF(V600E) mutation and the biology of papillary thyroid cancer
    Frasca, F.
    Nucera, C.
    Pellegriti, G.
    Gangemi, P.
    Attard, M.
    Stella, M.
    Loda, M.
    Vella, V.
    Giordano, C.
    Trimarchi, F.
    Mazzon, E.
    Belfiore, A.
    Vigneri, R.
    ENDOCRINE-RELATED CANCER, 2008, 15 (01) : 191 - 205